1. Advanced phase chronic myeloid leukaemia (CML) in the tyrosine kinase inhibitor era – a report from the Swedish CML register. (19th August 2016) Authors: Söderlund, Stina; Dahlén, Torsten; Sandin, Fredrik; Olsson‐Strömberg, Ulla; Creignou, Maria; Dreimane, Arta; Lübking, Anna; Markevärn, Berit; Själander, Anders; Wadenvik, Hans; Stenke, Leif; Richter, Johan; Höglund, Martin Journal: European journal of haematology Issue: Volume 98:Number 1(2017:Jan.) Page Start: 57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Dasatinib induces fast and deep responses in newly diagnosed chronic myeloid leukaemia patients in chronic phase: clinical results from a randomised phase‐2 study (NordCML006). (13th September 2014) Authors: Hjorth‐Hansen, Henrik; Stenke, Leif; Söderlund, Stina; Dreimane, Arta; Ehrencrona, Hans; Gedde‐Dahl, Tobias; Gjertsen, Bjørn Tore; Höglund, Martin; Koskenvesa, Perttu; Lotfi, Kourosh; Majeed, Waleed; Markevärn, Berit; Ohm, Lotta; Olsson‐Strömberg, Ulla; Remes, Kari; Suominen, Merja; Simonsson, Be... Journal: European journal of haematology Issue: Volume 94:Number 3(2015:Mar.) Page Start: 243 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Immunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first-line. (2nd September 2019) Authors: Kreutzman, Anna; Yadav, Bhagwan; Brummendorf, Tim H.; Gjertsen, Bjorn Tore; Hee Lee, Moon; Janssen, Jeroen; Kasanen, Tiina; Koskenvesa, Perttu; Lotfi, Kourosh; Markevärn, Berit; Olsson-Strömberg, Ulla; Stentoft, Jesper; Stenke, Leif; Söderlund, Stina; Udby, Lene; Richter, Johan; Hjorth-Hansen, He... Journal: Oncoimmunology Issue: Volume 8:Number 9(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. In Vivo Cytochrome P450 3A Isoenzyme Activity and Pharmacokinetics of Imatinib in Relation to Therapeutic Outcome in Patients With Chronic Myeloid Leukemia. Issue 2 (April 2016) Authors: Skoglund, Karin; Richter, Johan; Olsson-Strömberg, Ulla; Bergquist, Jonas; Aluthgedara, Warunika; Ubhayasekera, S. J. Kumari A.; Vikingsson, Svante; Svedberg, Anna; Söderlund, Stina; Sandstedt, Anna; Johnsson, Anders; Aagesen, Jesper; Alsenhed, Jonas; Hägg, Staffan; Peterson, Curt; Lotfi, Kourosh... Journal: Therapeutic drug monitoring Issue: Volume 38:Issue 2(2016:Apr.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Long‐term tolerability and efficacy after initial PegIFN‐α addition to dasatinib in CML‐CP: Five‐year follow‐up of the NordCML007 study. (31st August 2021) Authors: Flygt, Hjalmar; Söderlund, Stina; Stentoft, Jesper; Richter, Johan; Koskenvesa, Perttu; Mustjoki, Satu; Majeed, Waleed; Lübking, Anna; Dreimane, Arta; Markevärn, Berit; Stenke, Leif; Myhr Eriksson, Kristina; Gjertsen, Bjørn Tore; Gedde‐Dahl, Tobias; Dimitrijevic, Andreja; Udby, Lene; Olsson‐Ström... Journal: European journal of haematology Issue: Volume 107:Number 6(2021) Page Start: 617 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Plasma proteomics in CML patients before and after initiation of tyrosine kinase inhibitor therapy reveals induced Th1 immunity and loss of angiogenic stimuli. (November 2016) Authors: Söderlund, Stina; Christiansson, Lisa; Persson, Inger; Hjorth-Hansen, Henrik; Richter, Johan; Simonsson, Bengt; Mustjoki, Satu; Olsson-Strömberg, Ulla; Loskog, Angelica Journal: Leukemia research Issue: Volume 50(2016:Nov.) Page Start: 95 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Plasma proteomics of biomarkers for inflammation or cancer cannot predict relapse in chronic myeloid leukaemia patients stopping tyrosine kinase inhibitor therapy. (March 2020) Authors: Söderlund, Stina; Persson, Inger; Ilander, Mette; Guilhot, Joëlle; Hjorth-Hansen, Henrik; Koskenvesa, Perttu; Richter, Johan; Saussele, Susanne; Mustjoki, Satu; Olsson-Strömberg, Ulla Journal: Leukemia research Issue: Volume 90(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Successful tyrosine kinase inhibitor discontinuation outside clinical trials — data from the population‐based Swedish chronic myeloid leukaemia registry. (30th March 2021) Authors: Flygt, Hjalmar; Sandin, Fredrik; Dahlén, Torsten; Dremaine, Arta; Lübking, Anna; Markevärn, Berit; Myhr‐Eriksson, Kristina; Olsson, Karin; Olsson‐Strömberg, Ulla; Själander, Anders; Söderlund, Stina; Wennström, Lovisa; Wadenvik, Hans; Stenke, Leif; Höglund, Martin; Richter, Johan Journal: British journal of haematology Issue: Volume 193:Number 5(2021) Page Start: 915 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗